The effect of turmeric extracts on inflammatory mediator production

详细信息    查看全文

• 作者：R.C. Lantz ; G.J. Chen ; A.M. Solyom ; S.D. Jolad ; B.N. Timmermann
• 关键词：Curcuma longa L. (Zingiberaceae) ; Turmeric ; Anti-inflammatory ; Cytokines ; Prostaglandins ; TNF- ; none ; color ; black"" href=""/science?_ob=MathURL&_method=retrieve&_udi=B7GVW-4FPDR3D-7&_mathId=mml8&_user=398698
• 刊名：Phytomedicine
• 出版年：2005
• 出版时间：15 June 2005
• 年：2005
• 卷：12
• 期：6-7
• 页码：445-452
• 全文大小：257 K

文摘

Major compounds of several commonly used botanicals, including turmeric, have been purported to have anti-inflammatory actions. In order to test the anti-inflammatory activity of compounds isolated from rhizomes of Curcuma longa L. (Zingiberaceae), we have established an in vitro test system. HL-60 cells were differentiated and exposed to lipopolysaccharide (LPS) from Escherichia coli (1 μg/ml) in the presence or absence of botanical compounds for 24 h. Supernatants were collected and analyzed for the production of tumor necrosis factor alpha (TNF-α) and prostaglandin E₂ (PGE₂) using standard ELISA assays. Water-soluble extracts were not cytotoxic and did not exhibit biological activity. Organic extracts of turmeric were cytotoxic only at concentrations above 50 μg/ml. Crude organic extracts of turmeric were capable of inhibiting LPS-induced TNF-α (IC₅₀ value=15.2 μg/ml) and PGE₂ (IC₅₀ value=0.92 μg/ml) production. Purified curcumin was more active than either demethoxy- or bisdemethoxycurcumin. Fractions and subfractions of turmeric extracts collected via preparative HPLC had differing biological activity, ranging from no activity to IC₅₀ values of <1 μg/ml. For some fractions, subfractionation resulted in a loss of activity, indicating interaction of the compounds within the fraction to produce an anti-inflammatory effect. A combination of several of the fractions that contain the turmeric oils was more effective than the curcuminoids at inhibiting PGE₂. While curcumin inhibited COX-2 expression, turmeric oils had no effect on levels of COX-2 mRNA.